GROUP ONE TRADING, L.P. - BRAINSTORM CELL THERAPEUTICS ownership

BRAINSTORM CELL THERAPEUTICS's ticker is and the CUSIP is 10501E901. A total of 3 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of BRAINSTORM CELL THERAPEUTICS
ValueSharesWeighting
Q3 2023$18,248
-97.8%
91,200
-77.2%
0.00%
-100.0%
Q2 2023$824,206
+344.4%
400,100
+611.9%
0.00%
+200.0%
Q1 2023$185,460
-39.2%
56,200
-69.8%
0.00%0.0%
Q4 2022$304,876
-65.8%
185,900
-7.7%
0.00%
-50.0%
Q3 2022$891,000
+51.3%
201,500
-5.5%
0.00%
+100.0%
Q2 2022$589,000
+43.0%
213,300
+74.0%
0.00%
Q1 2022$412,000
-43.4%
122,600
-32.6%
0.00%
-100.0%
Q4 2021$728,000
+12.3%
181,900
-7.4%
0.00%0.0%
Q3 2021$648,000
-16.0%
196,400
-3.3%
0.00%0.0%
Q2 2021$771,000
-13.5%
203,000
-12.7%
0.00%0.0%
Q1 2021$891,000
+28.6%
232,600
+51.8%
0.00%0.0%
Q4 2020$693,000
-63.6%
153,200
+36.1%
0.00%
-83.3%
Q3 2020$1,905,000
+5.6%
112,600
-30.0%
0.01%
-25.0%
Q2 2020$1,804,000
+92.5%
160,900
-20.3%
0.01%0.0%
Q1 2020$937,000
+1387.3%
201,900
+1273.5%
0.01%
Q4 2019$63,000
-20.3%
14,700
-27.6%
0.00%
-100.0%
Q3 2019$79,000
+1480.0%
20,300
+1591.7%
0.00%
Q2 2019$5,000
-93.2%
1,200
-93.6%
0.00%
-100.0%
Q2 2018$73,000
+421.4%
18,700
+334.9%
0.00%
Q1 2018$14,000
-82.5%
4,300
-78.8%
0.00%
-100.0%
Q4 2017$80,000
+1.3%
20,300
+5.7%
0.00%0.0%
Q3 2017$79,000
+3850.0%
19,200
+3740.0%
0.00%
Q2 2017$2,000
-97.3%
500
-97.1%
0.00%
-100.0%
Q1 2017$74,000
+311.1%
17,400
+152.2%
0.00%
Q4 2016$18,000
+350.0%
6,900
+360.0%
0.00%
Q3 2016$4,0001,5000.00%
Other shareholders
BRAINSTORM CELL THERAPEUTICS shareholders Q1 2023
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 56,200$185,4600.00%
SIMPLEX TRADING, LLC 34,500$1130.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BRAINSTORM CELL THERAPEUTICS shareholders